Literature DB >> 28841233

Patients without comorbidities at the time of diagnosis of atrial fibrillation: causes of death during long-term follow-up compared to matched controls.

Tommy Andersson1, Anders Magnuson2, Ing-Liss Bryngelsson3, Ole Frøbert1, Karin M Henriksson4, Nils Edvardsson5, Dritan Poçi1.   

Abstract

BACKGROUND: Little is known about the long-term, cause-specific mortality risk in patients without comorbidities at the time of diagnosis of atrial fibrillation (AF).
METHODS: From a nation-wide registry of patients hospitalized with incident AF between 1995 and 2008 we identified 9 519 patients with a first diagnosed AF and no comorbidities at the time of AF diagnosis. They were matched with 12 468 controls. The follow-up continued until December 2008. Causes of death were classified according to the ICD-10 codes.
RESULTS: During follow-up, 11.1% of patients with AF and 8.3% of controls died. Cardiovascular diseases were the most common causes of death and the only diagnoses which showed significantly higher relative risk in patients with AF than controls (HR 2.0, 95% CI 1.8-2.3), and the relative risk was significantly higher in women than in men. Stroke was a more common cause among patients with AF, 13.1% versus 9.7% (HR 2.7, 95% CI 1.8-4.0), while cerebral hemorrhage was more common among controls, 4.7% versus 10.2% (HR 0.9, 95% CI 0.6-1.5). The time from AF diagnosis to death was 6.0 ± 3.1 years.
CONCLUSIONS: In patients with incident AF and no known comorbidities at the time of AF diagnosis, only cardiovascular diseases were more often causes of death as compared to controls. Women carried a significantly higher relative risk than men.
© 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  atrial fibrillation; cause of death; idiopathic; morbidity; mortality

Mesh:

Year:  2017        PMID: 28841233      PMCID: PMC6490559          DOI: 10.1002/clc.22776

Source DB:  PubMed          Journal:  Clin Cardiol        ISSN: 0160-9289            Impact factor:   2.882


  18 in total

Review 1.  Epidemiological profile of atrial fibrillation: a contemporary perspective.

Authors:  Teresa S M Tsang; Yoko Miyasaka; Marion E Barnes; Bernard J Gersh
Journal:  Prog Cardiovasc Dis       Date:  2005 Jul-Aug       Impact factor: 8.194

2.  Causes of death and influencing factors in patients with atrial fibrillation: a competing-risk analysis from the randomized evaluation of long-term anticoagulant therapy study.

Authors:  Eloi Marijon; Jean-Yves Le Heuzey; Stuart Connolly; Sean Yang; Janice Pogue; Martina Brueckmann; John Eikelboom; Ellison Themeles; Michael Ezekowitz; Lars Wallentin; Salim Yusuf
Journal:  Circulation       Date:  2013-09-09       Impact factor: 29.690

Review 3.  Mortality associated with atrial fibrillation in patients with myocardial infarction: a systematic review and meta-analysis.

Authors:  Patricia Jabre; Véronique L Roger; Mohammad H Murad; Alanna M Chamberlain; Larry Prokop; Frédéric Adnet; Xavier Jouven
Journal:  Circulation       Date:  2011-04-04       Impact factor: 29.690

4.  The occurrence of cardiovascular disease during 5-year follow-up in patients with idiopathic atrial fibrillation.

Authors:  B Weijs; C B de Vos; R G Tieleman; F E C M Peeters; I Limantoro; A A Kroon; E C Cheriex; R Pisters; H J G M Crijns
Journal:  Europace       Date:  2012-07-10       Impact factor: 5.214

5.  Effect of new versus known versus no atrial fibrillation on 30-day and 10-year mortality in patients with acute coronary syndrome.

Authors:  Dritan Poçi; Marianne Hartford; Thomas Karlsson; Nils Edvardsson; Kenneth Caidahl
Journal:  Am J Cardiol       Date:  2012-04-20       Impact factor: 2.778

6.  Mortality trends in patients diagnosed with first atrial fibrillation: a 21-year community-based study.

Authors:  Yoko Miyasaka; Marion E Barnes; Kent R Bailey; Stephen S Cha; Bernard J Gersh; James B Seward; Teresa S M Tsang
Journal:  J Am Coll Cardiol       Date:  2007-02-16       Impact factor: 24.094

7.  Increasing prevalence of atrial fibrillation and flutter in the United States.

Authors:  Gerald V Naccarelli; Helen Varker; Jay Lin; Kathy L Schulman
Journal:  Am J Cardiol       Date:  2009-12-01       Impact factor: 2.778

8.  Atrial fibrillation and the risk of sudden cardiac death: the atherosclerosis risk in communities study and cardiovascular health study.

Authors:  Lin Y Chen; Nona Sotoodehnia; Petra Bůžková; Faye L Lopez; Laura M Yee; Susan R Heckbert; Ronald Prineas; Elsayed Z Soliman; Selcuk Adabag; Suma Konety; Aaron R Folsom; David Siscovick; Alvaro Alonso
Journal:  JAMA Intern Med       Date:  2013-01-14       Impact factor: 21.873

9.  External review and validation of the Swedish national inpatient register.

Authors:  Jonas F Ludvigsson; Eva Andersson; Anders Ekbom; Maria Feychting; Jeong-Lim Kim; Christina Reuterwall; Mona Heurgren; Petra Otterblad Olausson
Journal:  BMC Public Health       Date:  2011-06-09       Impact factor: 3.295

10.  All-cause mortality in 272,186 patients hospitalized with incident atrial fibrillation 1995-2008: a Swedish nationwide long-term case-control study.

Authors:  Tommy Andersson; Anders Magnuson; Ing-Liss Bryngelsson; Ole Frøbert; Karin M Henriksson; Nils Edvardsson; Dritan Poçi
Journal:  Eur Heart J       Date:  2013-01-14       Impact factor: 29.983

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.